{"id":"W2590693960","doi":"10.1200/jco.2014.32.4_suppl.473","title":"Biomarker analysis from a phase III trial (GOLD) of dovitinib (Dov) versus sorafenib (Sor) in patients with metastatic renal cell carcinoma after one prior VEGF pathway–targeted therapy and one prior mTOR inhibitor therapy.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Sorafenib; Biomarker; Oncology; Hazard ratio; Internal medicine; Proportional hazards model; Renal cell carcinoma; Progression-free survival; Cohort; Overall survival; Confidence interval; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002430113,0.0006519088,0.00154341,0.0002739418,0.0002450504,0.0008949178,0.0004111996,0.0006212773,0.001202633],"category_scores_gemma":[0.002092035,0.0002413398,0.0013078,0.0003322272,0.0004184565,0.0004776075,0.0003703449,0.0009993641,0.0002017747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008914686,"about_ca_system_score_gemma":0.0009533273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005276232,"about_ca_topic_score_gemma":0.001581907,"domain_scores_codex":[0.9991094,0.0004251467,0.00005815261,0.0001759913,0.0001090149,0.0001222359],"domain_scores_gemma":[0.9986054,0.0003689943,0.0004054751,0.0001233922,0.00007578782,0.0004209625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7301829,0.006804631,0.1380092,0.0009989227,0.008903583,0.0003258207,0.0002577377,0.003314023,0.02865571,0.0003403467,0.004651374,0.07755577],"study_design_scores_gemma":[0.288614,0.2808753,0.3936252,0.0001321972,0.008039913,0.001169722,0.00022122,0.005056315,0.01195882,0.0006780035,0.009516776,0.0001125615],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967193,0.001559696,0.0001848972,0.0001705729,0.00003641036,0.0001985277,0.0006991913,0.00001763118,0.000413702],"genre_scores_gemma":[0.9958656,0.000315816,0.0004610147,0.000269934,0.00004055411,0.0001962684,0.002528326,0.000005233071,0.0003172596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002430113,"threshold_uncertainty_score":0.01285183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09803582891267835,"score_gpt":0.3702265866734542,"score_spread":0.2721907577607758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}